Valuation: Renata PLC

Market Cap 54.27B 439M 380M 355M 326M 616M 41.75B 622M 4.17B 1.64B 20.89B 1.65B 1.61B 69.19B P/E 2026 *
19.3x
P/E 2027 * 13.1x
Enterprise Value 54.27B 439M 380M 355M 326M 616M 41.75B 622M 4.17B 1.64B 20.89B 1.65B 1.61B 69.19B EV / Sales 2026 *
1.14x
EV / Sales 2027 * 0.99x
Free-Float
17.05%
Yield 2026 *
1.2%
Yield 2027 * 3.09%
1 day+0.57%
1 week-0.61%
Current month+0.64%
1 month+2.11%
3 months+13.97%
6 months+6.10%
Current year+20.78%
1 week 468.6
Extreme 468.6
475.5
1 month 457.2
Extreme 457.2
483.2
Current year 381.8
Extreme 381.8
488
1 year 372
Extreme 372
547
3 years 372
Extreme 372
1,217.9
5 years 372
Extreme 372
1,289.72
10 years 372
Extreme 372
1,289.72
Manager TitleAgeSince
Chief Executive Officer - 01/01/2002
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member - 01/01/2002
Chairman 84 -
Director/Board Member - 27/08/2013
Change 5-day change 1-year change 3-year change Capi.($)
+0.57%-0.61%-7.34%-61.15% 439M
+4.86%-3.32%+52.73%+160.26% 1,043B
+1.04%-2.99%+50.87%+52.38% 621B
+0.98%-6.49%+24.00%+66.66% 435B
+0.82%+4.07%+47.95%+38.87% 361B
+1.05%-0.82%+36.13%+39.94% 293B
+0.40%-5.15%+9.15%+10.83% 251B
+4.57%+5.21%+35.91%+67.64% 220B
+0.73%-10.38%+2.44%-45.66% 201B
-2.58%-0.73%+17.16%+67.46% 164B
Average +0.81%-3.49%+26.90%+39.73% 358.96B
Weighted average by Cap. +0.87%-3.79%+38.56%+76.30%

Financials

2026 *2027 *
Net sales 47.45B 384M 332M 310M 285M 538M 36.5B 544M 3.64B 1.43B 18.26B 1.44B 1.41B 60.49B 55.08B 446M 386M 360M 331M 625M 42.38B 632M 4.23B 1.66B 21.2B 1.67B 1.64B 70.22B
Net income 2.81B 22.75M 19.7M 18.36M 16.89M 31.89M 2.16B 32.24M 216M 84.7M 1.08B 85.43M 83.55M 3.58B 4.39B 35.5M 30.74M 28.66M 26.36M 49.76M 3.38B 50.32M 337M 132M 1.69B 133M 130M 5.59B
Net Debt - -
Logo Renata PLC
Renata PLC is a Bangladesh-based pharmaceutical company. The Company is engaged in the manufacturing, marketing and distribution of pharmaceuticals, animal health products, oncology-based products, agro-based products, poultry products, and consumer products. It operates in several modalities, such as oral solids dosage forms, which include tablets, capsules, OROS, oral dispersible tablets; soft gels injectables, which include hormone injectables, general injectables and oncology injectables; inhalers, which include DPI and MDI, and nutraceutical products. Its offering includes anthelmintic, live vaccines, nutrition products, vitamins & minerals, anti-gout, anti-spasmodic, and anti-allergic. The Company has approximately 14 manufacturing facilities spread over three manufacturing sites.
Employees
8,366
Date Price Change Volume
04/08/26 BDT 473.20 +0.57% 38,912
03/08/26 BDT 470.50 +0.19% 24,289
02/08/26 BDT 469.60 -0.13% 59,357
30/07/26 BDT 470.20 -1.24% 61,540
29/07/26 BDT 476.10 -0.63% 56,127
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
473.20BDT
Average target price
615.05BDT
Spread / Average Target
+29.98%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RENATA Stock